Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFirst Affiliated Hospital of Zhejiang University

About this trial

To evaluate the efficacy and safety of combination of anticoagulant and antiplatelet therapy on the patency of iliac vein at 12-month post stenting in patients with acute proximal DVT and ipsilateral iliac vein stenosis who received percutaneous mechanic thrombectomy and iliac vein stenting.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Rivaroxaban
  • Aspirin

Treatment groups

172 Participants
are divided into 1 treatment group

Sponsors and collaborators

First Affiliated Hospital of Zhejiang University

Lead sponsor

Zhejiang University

Collaborator

Ningbo No.2 Hospital

Collaborator

Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University

Collaborator

The Central Hospital of Lishui City

Collaborator

Taizhou Enze Medical Center Group

Collaborator

Taizhou First People's Hospital

Collaborator

Boston Scientific Corporation

Collaborator